Clinical Trials
31 trialsCALPRO
Assistance Publique - Hôpitaux de Paris
Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow Transplantation
University of Michigan Rogel Cancer Center
THROMBLEUKEMIA
CHU de Reims
REALL CD9
Rennes University Hospital
GATA-2
Institut Claudius Regaud
OPTIFIL
Assistance Publique - Hôpitaux de Paris
MAHATMAt
Assistance Publique Hopitaux De Marseille
A Novel "Pediatric-Inspired" Regimen With Reduced Myelosuppressive Drugs for Adults (Aged 18-60) With Newly Diagnosed Ph Negative Acute Lymphoblastic Leukemia
Memorial Sloan Kettering Cancer Center
PIONEER
Gustave Roussy, Cancer Campus, Grand Paris
SCTMICROBIOM
National Cancer Institute, Slovakia
VISCOTHEM-1
Centre Hospitalier Annecy Genevois
MinimALL
University of Erlangen-Nürnberg Medical School
BIO-TIMER
University Hospital, Clermont-Ferrand
CPI-613 Given With Metformin in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)
Wake Forest University Health Sciences
Description of the Immune Deficiency in Patients With Untreated Chronic Lymphocytic Leukemia and Search for Predictive Factors of Infectious Risk
CHU de Reims
Natural Killer Cells Before and After Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia
M.D. Anderson Cancer Center
CReSCT
Melbourne Health
PLANET
Centre Leon Berard
DIMATE
Assistance Publique Hopitaux De Marseille
TTV-CART
Institut Paoli-Calmettes
OXYLAM
University Hospital, Toulouse
Interest of a Therapeutic Follow-up of the Cytarabine in the Acute Myeloid Leukaemia: Is There Constitutional Biomarkers
Assistance Publique Hopitaux De Marseille
CCR7-CD4-DPL
University Hospital, Lille
LEA-JA
Institut Paoli-Calmettes
Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies
M.D. Anderson Cancer Center
LAM-PTK7
Institut Paoli-Calmettes
Evaluation of Cytidine Deaminase for Patient Suffering of a Myelodysplastic Syndrom or an AML Treated by Azacytidine
Assistance Publique Hopitaux De Marseille
A New Dosing Regimen for Posaconazole Prophylaxis in Children Based on Body Surface Area
Universitaire Ziekenhuizen KU Leuven
Natural Killer Cells Functions, Tumoral Escape to Immune System and Regulation of Natural Cytotoxixity Receptors in Haematological Malignancies
Assistance Publique Hopitaux De Marseille
A Multi-Center Phase 2 Study of VEGF Trap as a Single Agent in Acute Myeloid Leukemia
Vanderbilt-Ingram Cancer Center
Leukemia Cell Cultures for Research of New Anti-Cancer Therapies
University Hospital, Strasbourg, France